Ajanta Pharma Limited, a Rs.1,450 crore plus Mumbai based specialty focused pharmaceutical formulation company, has received final approval from the United States Food and Drug Administration (FDA) for its 3 Abbreviated New Drug Applications (ANDAs), montelukast tablets, 10mg, montelukast sodium chewable tablets, 4mg & 5mg and montelukast oral granules.

